Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Integrated bioinformatic analysis identifies UBE2Q1 as a potential prognostic marker for high grade serous ovarian cancer

Fig. 5

UBE2Q1 functions as a poor prognostic marker for hormone independent ER−/HER2- breast cancers. a Increased mRNA expression of UBE2Q1 in tumor samples of hormone independent basal-like breast cancer patients in comparison to HER2- enriched (HER2-E), Luminal-A, Luminal-B and normal-like hormone dependent breast cancer subtypes (p value < 0.0001). b Kaplan Meier survival plots correlate high expression of UBE2Q1 (Probe id = 222480_at) with reduced probability of relapse free survival of hormone independent ER−/HER2- breast cancer patients

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us